Predictors for Recurrence of Atrial Fibrillation After Electrical Cardioversion
- Conditions
- Atrial Fibrillation
- Registration Number
- NCT03346863
- Lead Sponsor
- Vestre Viken Hospital Trust
- Brief Summary
In patients with persistent atrial fibrillation (AF), electrical cardioversion is very effective in restoring sinus rhythm if modern, biphasic cardioverters are used. However, approximately 50 per cent of the successfully cardioverted patients experience a recurrence of AF within a few weeks. Therefore, valid predictors for AF recurrence would be of great clinical relevance, to avoid unnecessary procedures.
In the PRE-ELECTRIC study, we will investigate the predictive value of potential new biomarkers with respect to AF recurrence within 30 days after electrical cardioversion. We will investigate serum and plasma biomarkers, electrocardiological markers and echocardiographic variables in this respect. The study will be undertaken as a prospective cohort study at Bærum Hospital, Vestre Viken Hospital Trust, with national and international collaborators.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 270
- Patients > 18 years referred for electrical cardioversion for persistent atrial fibrillation
- Signed, informed consent
- Patients < 18 years
- Patients with paroxysmal atrial fibrillation
- Patients unwilling to participate or without consent competence
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Atrial fibrillation recurrence 30 days after electrical cardioversion ECG-documented atrial fibrillation recurrence after successful cardioversion
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Bærum Hospital, Vestre Viken
🇳🇴Sandvika, Bærum, Norway